Clinical Trials in Dallas

Showing 5481-5500 of 17,468 trials

Nemaline Myopathy Clinical Research Network (NM-CTRN)

NCT06774703

The goal of this study is to establish a research network to help define the natural disease history and clinical outcome measures for Nemaline Myopathy (NM).

Nemaline Myopathy

Stanford University50 participantsStarted Jan 2025

Palo Alto, California, United States • Bethesda, Maryland, United States • Boston, Massachusetts, United States +3 more locations

COMPLETEDPhase 1< 1 mile

Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

NCT04121676

This study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, PK, and PD profiles of AGEN2373 as a monotherapy and in combination with botensilimab (also known as AGEN1181), and to assess the maximum tolerated dose (MTD) in subjects with advanced solid tumors.

Advanced Cancer

Agenus Inc.91 participantsStarted Sep 2019

Los Angeles, California, United States • Aurora, Colorado, United States • Coral Gables, Florida, United States +9 more locations

Nemaline Myopathy Clinical Research Network (NM-CTRN)

Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

Find Trials by Condition in Dallas

Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer

Emergency Department-Initiated Buprenorphine Validation Network Trial

Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain

A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response

Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed

Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation

A Study of TAK-861 in Participants With Narcolepsy Type 2

A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

Multi-center Clinical Study to Evaluate the C2 CryoBalloon Focal Ablation System

HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)

Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques